These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4403699)

  • 1. The influence of levodopa and adrenergic blockade on growth hormone and prolactin secretion in the MStTW15 tumor bearing rat.
    Malarkey WB; Daughaday WH
    Endocrinology; 1972 Nov; 91(5):1314-7. PubMed ID: 4403699
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent effects of medroxyprogesterone acetate on growth hormone and prolactin in the MStTW15 tumor bearing rat.
    Malarkey WB; Daughaday WH
    Endocrinology; 1972 Apr; 90(4):909-14. PubMed ID: 5011060
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.
    Massara F; Camanni F
    J Endocrinol; 1972 Aug; 54(2):195-206. PubMed ID: 4403626
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental modification of the sleep-induced peak of growth hormone secretion.
    Lucke C; Glick SM
    J Clin Endocrinol Metab; 1971 Jun; 32(6):729-36. PubMed ID: 4397015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study, in the dog, of effect of alpha and beta blocking agents on arterial pressure effects of L-Dopa].
    Patay M; Lacroix P; Le Clec'h G; Linée P; Van den Driessche J
    C R Seances Soc Biol Fil; 1973; 167(8):1266-74. PubMed ID: 4152729
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic and serotoninergic control of growth hormone secretion in adult male rats.
    Collu R; Fraschini F; Visconti P; Martini L
    Endocrinology; 1972 May; 90(5):1231-7. PubMed ID: 4401150
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of radioimmunoassayable growth hormone and prolactin during hypothroidism.
    Peake GT; Birge CA; Daughaday WH
    Endocrinology; 1973 Feb; 92(2):487-93. PubMed ID: 4682861
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE; Jacobs LS; Daughaday WH
    Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses.
    Birge CA; Jacobs LS; Hammer CT; Daughaday WH
    Endocrinology; 1970 Jan; 86(1):120-30. PubMed ID: 5409444
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic manipulation and thyrotropin releasing hormone (TRH)-induced thyrotropin (TSH) release.
    Woolf PD; Lee LA; Schalch DS
    J Clin Endocrinol Metab; 1972 Oct; 35(4):616-8. PubMed ID: 4403331
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cerebroventricular perfusion of alpha and beta adrenergic blocking agents on carotid occulsion response.
    Abraham GJ; Ahmed SS; Verghese KG
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):105-11. PubMed ID: 4394964
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma growth hormone in the anesthetized rat. Effects of dibutyryl cyclic AMP, prostaglandin E 1 , adrenergic agents, vasopressin, chlorpromazine, amphetamine and L-dopa.
    Kato Y; Dupre J; Beck JC
    Endocrinology; 1973 Jul; 93(1):135-46. PubMed ID: 4351310
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenocortical structure and function in rats bearing an adrenocorticotrophic hormone, growth hormone, and prolactin-secreting tumor.
    Nickerson PA; Brownie AC; Molteni A
    Lab Invest; 1970 Oct; 23(4):368-77. PubMed ID: 4360549
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of antiadrenergic drugs on ovulation in hens.
    Kao LW; Nalbandov AV
    Endocrinology; 1972 May; 90(5):1343-9. PubMed ID: 4401151
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacologic blockade of the circhoral mode of LH secretion in the ovariectomized rhesus monkey.
    Bhattacharya AN; Dierschke DJ; Yamaji T; Knobil E
    Endocrinology; 1972 Mar; 90(3):778-86. PubMed ID: 4400337
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa suppression of prolactin in nonpuerperal galactorrhea.
    Malarkey WB; Jacobs LS; Daughaday WH
    N Engl J Med; 1971 Nov; 285(21):1160-3. PubMed ID: 5107027
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin synthesis and secretion in a patient with the Forbes Albright syndrome.
    Friesen H; Webster BR; Hwang P; Guyda H; Munro RE; Read L
    J Clin Endocrinol Metab; 1972 Jan; 34(1):192-9. PubMed ID: 5061774
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of sex hormones on the in vitro synthesis of prolactin and growth hormone in normal and pituitary tumor-bearing rats.
    MacLeod RM; Abad A; Eidson LH
    Endocrinology; 1969 Jun; 84(6):1475-83. PubMed ID: 4305502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.